Charles Explorer logo
🇬🇧

Patent hemostasis and comparison of two compression devices after transradial coronary catheterization and intervention

Publication |
2018

Abstract

Aim: The aim of this study was to compare two compression devices after transradial coronary catheterization and intervention. Methods: Out of 280 consecutive patients who underwent cardiac catheterization and intervention (n = 74) as a part of a same-day discharge program, 140 patients were applied the TR Band (TB) compression device and 140 the Seal-One (SO) compression device.

The time needed to achieve patent hemostasis, duration of compression and local complications were assessed. Results: In the TB group, patent hemostasis was achieved in 17.5 + 10.3 min (min), in the SO group in 21.4 + 10.5 min (p = NS).

The duration of radial artery compression was 90.7 + 38.4 min in the TB group and 64.0 + 26.5 min in the SO group (p = 5 cm did not differ between the two groups (6.4% vs. 6.4%, p = NS), the incidence of hematomas larger than 10 cm was 0.7% in the TB group and 1.4% in the SO group (p = NS). No radial artery occlusion or other local complications were found.

Conclusion: Postprocedural radial artery compression with TR Band and Seal-One devices is associated with early patent hemostasis and a short duration of compression. The use of the Seal-One device was related to a shorter mean compression time in this study.

No radial artery occlusion at discharge, nor any other local complications occurred following the radial artery compression, except for several clinically insignificant hematomas.